Topics

Promising data from US trial using gene-edited immunotherapy in humans

04:44 EST 7 Nov 2019 | SmartBrief

Preliminary data from the University of Pennsylvania Perelman School of Medicine's trial of CRISPR-edited T cells in three hu -More

Original Article: Promising data from US trial using gene-edited immunotherapy in humans

NEXT ARTICLE

More From BioPortfolio on "Promising data from US trial using gene-edited immunotherapy in humans"

Quick Search